Arca
Skip to content
Tools
Tools

PTGER3: Prostaglandin E2 receptor EP3 subtype

Receptor for prostaglandin E2 (PGE2).

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PTGER3, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved1

  • Misoprostol

Phase 31

  • Sepetaprost

Phase 20

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      MisoprostolBoxed warningApprovedPfizerSmall moleculeAgonistProstanoid EP3 receptor agonist44
      SepetaprostPhase 3—Small moleculeAgonistProstanoid EP3 receptor agonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
      Intrauterine Misoprostol in Cesarean Delivery: Effect on Postpartum HemorrhageMisoprostolPhase 4Not yet recruitingBagcilar Training and Research HospitalNov 17, 2026
      'No-test' Tele-abortion: a Multi-centre Randomised Controlled TrialMisoprostolNot applicableNot yet recruitingKarolinska InstitutetOct 9, 2026
      Improving the Childbirth Experience for Women Who Have Undergone Cervical Ripening by Involving Them in the Choice of Ripening TechniqueMisoprostolNot applicableNot yet recruitingCentre Hospitalier Régional Metz-ThionvilleOct 2, 2026
      Second Trimester Abortion With Letrozole and Misoprostol Compared to Misoprostol AloneMisoprostolPhase 1 / Phase 2Not yet recruitingSohag UniversityAug 17, 2026
      The Value of Pretreatment With Letrozole on Induction Time of Medical Evacuation With Misoprostol in Cases of Missed AbortionMisoprostolNot applicableNot yet recruitingCairo UniversityAug 7, 2026
      Ripening Approaches for Prompt Induction and Delivery - Sequential Versus Concurrent Dilapan-S and Misoprostol to Achieve Vaginal Delivery (RAPID-DS)MisoprostolNot applicableRecruitingOchsner Health SystemJul 21, 2026
      Office Hysteroscopy in Postmenopausal Women: A Randomized Trial of Cervical Preparation StrategiesMisoprostolNot applicableRecruitingFaculty of Medicine of TunisJul 13, 2026
      Combined Misoprostol and Cervical Balloon vs Misoprostol Alone for Induction on the First Day in PrimiparasMisoprostolPhase 4Not yet recruitingPeking University First HospitalJul 8, 2026

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      Peptic ulcer disease
      0.46
      Pregnancy
      0.39
      Uterine corpus leiomyoma
      0.38
      Pain
      0.37
      Neurodegenerative disease
      0.37
      Gastroesophageal reflux disease
      0.37

      Genes and related targets

      Complexes and families that share a gene with this target
      Genes
      PTGER3

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3710, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P43115, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.